Related Experiment Video
Updated: May 1, 2026
Cholesterol Efflux Assay
Published on: March 6, 2012
miR-613 regulates cholesterol efflux by targeting LXRα and ABCA1 in PPARγ activated THP-1 macrophages
Ranzun Zhao1, Jian Feng1, Guoxiang He1
1Department of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
Abstract:
Cholesterol efflux from macrophages is a critical mechanism to prevent the development of atherosclerosis. Although PPARγ is known to be a potent sterol sensor that play a fundamental role in cholesterol metabolism, the potential effects of PPARγ responsive miRNA still need to be revealed. In this study, we found that miR-613 is inversely correlated with LXRα and ABCA1 in PPARγ activated THP-1 cells. PPARγ negatively regulates the expression of miR-613 at transcriptional level, and miR-613 suppressed LXRα and ABCA1 by targeting the 3'-UTR of their mRNAs. Furthermore, downregulation of LXRα and ABCA1 by miR-613 inhibited cholesterol efflux from PPARγ activated THP-1 macrophages. These results revealed an alternative mechanism for PPARγ regulation and provided a potential target for the treatment of cholesterol metabolic diseases.
Insights
Peroxisome proliferator-activated receptor gamma (PPARγ) regulates microRNA-613 (miR-613), which in turn suppresses cholesterol efflux. This finding offers a new therapeutic target for cholesterol metabolic diseases.
Area of Science:
- Molecular biology
- Cell biology
- Biochemistry
Background:
- Cholesterol efflux from macrophages is crucial for preventing atherosclerosis.
- Peroxisome proliferator-activated receptor gamma (PPARγ) is a key regulator of cholesterol metabolism.
- The role of PPARγ-responsive microRNAs (miRNAs) in this process remains largely unknown.
Purpose of the Study:
- To investigate the role of PPARγ-responsive miRNAs in regulating cholesterol metabolism.
- To elucidate the mechanism by which PPARγ influences cholesterol efflux via miRNA.
Main Methods:
- THP-1 cells were activated with PPARγ agonists.
- Expression levels of miR-613, LXRα, and ABCA1 were measured.
- Luciferase reporter assays were used to confirm miRNA targeting.
- Cholesterol efflux assays were performed.
Main Results:
- miR-613 expression was inversely correlated with LXRα and ABCA1 in PPARγ-activated THP-1 cells.
- PPARγ was found to negatively regulate miR-613 transcription.
- miR-613 directly targeted the 3'-UTR of LXRα and ABCA1 mRNAs, suppressing their expression.
- The suppression of LXRα and ABCA1 by miR-613 inhibited cholesterol efflux.
Conclusions:
- PPARγ regulates cholesterol efflux through a novel pathway involving miR-613.
- miR-613 acts as a suppressor of LXRα and ABCA1, thereby inhibiting cholesterol efflux.
- This study reveals a new mechanism for PPARγ-mediated cholesterol regulation and identifies miR-613 as a potential therapeutic target for cholesterol metabolic disorders.
